Archive for MHRA Updates
Company led medicines recall: A.Vogel Ltd, Linoforce granules 12 years plus (THR 13668/0021), CLMR (22)A/05
Source: MHRA / Gov.uk A.Vogel Ltd is recalling a specific batch of Pharmacy only medicine due to a small number of packs that were inadvertently supplied to non-pharmacy retail outlets....
Dame Lesley Regan appointed Women’s Health Ambassador
Source: Department of Health and Social Care 17th June 2022 Professor of Obstetrics and Gynaecology to drive system level changes to close the gender health gap Women’s Health Ambassador to...
Class 4 Medicines Defect Information: Altan Pharma Limited, Phenylephrine 0.08 mg/ml – solution for injection/infusion, EL(22)A/29
Source: MHRA / Gov.uk 16th June 2022 Altan Pharma Limited have identified an error relating to the product packaging. The incorrect concentration of phenylephrine base is provided on the overwrapping...
Company led medicines recall: PCCA Limited, Ketamine 50mg in 5ml Oral Solution and Ketamine 100mg in 5ml Oral Solution (unlicensed medicines), CLMR (22)A/04
Source: MHR / Gov.uk PCCA Limited have been made aware of an issue with the appearance of Ketamine 50mg in 5ml Oral Solution and Ketamine 100mg in 5ml Oral Solution....
Class 2 Medicines Recall: Bristol Laboratories Limited, Phenobarbital 60 mg Tablets, EL(22)A/28
Source: MHRA / Gov.uk 13.6.22 Bristol Laboratories Limited are recalling a batch of this product as a precautionary measure due to low dissolution test results reported during ongoing stability studies....
Shortage of Hydrocortisone 2.5mg muco-adhesive buccal tablets
Source: SPS 6th June 2022 Medicines affected Medicines Supply Notification Number: MSN/2022/054 Medicine ...
Class 4 Medicines Defect Information: OxyContin 20 mg prolonged release tablets, EL (22)A/27
Source: MHRA/ Gov.uk 1st June 2022 Napp Pharmaceuticals Limited have identified an error relating to the Braille printed on the cartons. The Braille message on the Oxycontin 20mg prolonged release...
Class 4 Medicines Defect Information: OxyContin 20 mg prolonged release tablets, EL (22)A/27
Source: MHRA/ Gov.uk Napp Pharmaceuticals Limited have identified an error relating to the Braille printed on the cartons. The Braille message on the Oxycontin 20mg prolonged release tablets incorrectly states...
Class 4 Medicines Defect Information: Esomeprazole 40mg Powder for Solution for Injection/Infusion, EL (22)A/26
Source: MHRA / Gov.uk 31.5.22 DEMO SA PHARMACEUTICAL INDUSTRY has informed us that the Product Code/GTIN (PC) number found on the above batch is incorrect. The GTIN number that should...
Class 2 Medicines Recall: Quadrant Pharmaceuticals Ltd, Mefenamic Acid 500mg film coated tablets, EL (22)A/23
Source: MHRA / Gov.uk 17.5.22 Quadrant Pharmaceuticals Ltd are recalling a specific batch of Mefenamic Acid 500mg Film-Coated Tablets as a precautionary measure, due to observations of a defective layer...
Shortage of Estradiol (Sandrena) 1mg gel sachets-Medicines Supply Tool update
Source: SPS.nhs.uk * 16th May 22 Status: Supply returning Impact tier: 1 · Low impact Shortage start: – Anticipated re-supply date: 31 May 2022 BNF chapters: 07 – Obstetrics, Gynae & Urinary...
Class 4 Medicines Defect Information: GlaxoSmithKline UK Ltd, Zovirax I.V. 500 mg, EL (22)A/22
Source: MHRA / Gov.uk 9.5.22 GlaxoSmithKline UK Ltd have informed the MHRA that an incorrect version of the Summary of Product Characteristics section 4.2 and the Patient Information Leaflet is...
